If you may be in danger, call or text 988. Call 911 for emergencies. More crisis resources
For education, not medical advice. Always talk with your own doctor or prescriber about your treatment.

Adderall vs Vyvanse

How amphetamine and lisdexamfetamine compare, two amphetamine-based stimulants for ADHD.

How they're similar

Adderall and Vyvanse are both amphetamine-class stimulants. They share a long list of features.

  • Both are used to treat ADHD, and both start to work the same day they are taken, often within about an hour.
  • Both work by increasing dopamine and norepinephrine, two chemical messengers involved in attention and self-control.
  • Both are Schedule II controlled substances. Both carry an FDA boxed warning about the risk of misuse, abuse, and addiction.
  • Both need a new prescription each time rather than a standard refill, so both call for planning ahead.
  • Both can reduce appetite, disturb sleep, and raise heart rate and blood pressure.
  • Both are effective for ADHD when used as prescribed.

How they differ

The differences are real but narrow, and most of them trace back to one design choice. Vyvanse is a prodrug, while Adderall is taken in an already active form. The table below sums up the core points, with more detail underneath.

Adderall (amphetamine salts) Vyvanse (lisdexamfetamine)
Drug type Amphetamine-based stimulant Amphetamine-based stimulant, prodrug
Formulations Immediate-release and extended-release One long-acting form
Onset and duration Immediate-release is short-acting, a few hours; extended-release lasts most of the day Smooth, gradual onset, long and steady from one morning dose
Day-to-day feel Immediate-release has a more noticeable rise and fall; extended-release is steadier Long and smooth, with less of a peak and crash
Misuse potential Schedule II; immediate-release is more readily misused Schedule II; prodrug design makes it somewhat harder to misuse
Other approved use None beyond ADHD Also approved for binge eating disorder in adults

The biggest difference is the prodrug design. Vyvanse is inactive as taken, and the body gradually converts it into the active stimulant. That conversion gives a smooth, gradual onset and a long, steady effect from one morning dose. Adderall is active as taken. It comes in an immediate-release form, which is short-acting and lasts a few hours, and an extended-release form, which lasts most of the day.

That design also shapes how each one feels over a day. Vyvanse is long and smooth, with less of a peak and crash, and people often describe steady focus rather than a jolt. Immediate-release Adderall is shorter, with a more noticeable rise and fall, and some people feel a sharper edge as it comes on or wears off. Extended-release Adderall sits in between. For someone who notices a clear dip in mood or a rise in irritability as a dose leaves the system, sometimes called rebound, the smoother shape of Vyvanse or extended-release Adderall can help.

The duration difference has practical effects. A person who needs steady coverage from morning into the evening, and who would rather take one dose, may do well on Vyvanse or extended-release Adderall. A person who only needs a stimulant at certain times, such as for a few hours of focused work, may find immediate-release Adderall a better fit, since it can be timed and does not commit them to all-day coverage. Immediate-release Adderall can also be used to extend coverage late in the day, on top of a long-acting morning dose, though that is a decision for a prescriber.

Misuse potential differs for the same reason. Because Vyvanse must be converted by the body to become active, it is somewhat harder to misuse than an immediate-release stimulant. Immediate-release Adderall is more readily misused. Both are still Schedule II controlled substances, and both carry the same boxed warning. For someone with a history of substance use problems, the prodrug design may be one factor a prescriber weighs, alongside everything else.

Approved uses differ slightly. Vyvanse is also approved for moderate to severe binge eating disorder in adults, a condition marked by recurring episodes of eating large amounts of food with a sense of loss of control. Adderall is approved for ADHD and not for binge eating disorder. Cost is another practical point. Both are now available as generics, which has lowered the price for many people, though coverage and price still vary by insurance plan and pharmacy.

Side effects compared

The everyday side effects of these two medications overlap closely, since both are amphetamine-class stimulants. Both can reduce appetite, disturb sleep, and raise heart rate and blood pressure. Both can cause dry mouth, headache, irritability, and a jittery or anxious feeling for some people. Both can rarely worsen anxiety or agitation, and both call for caution in anyone with a serious heart condition, so a prescriber asks about heart history before starting.

The shape of the side effects can differ with the shape of the dose. Immediate-release Adderall rises and falls faster, so some people notice a sharper edge as it comes on or wears off, including rebound irritability as it leaves the system. Vyvanse and extended-release Adderall are steadier across the day, which can smooth out that edge. Many side effects ease over the first weeks as the body adjusts, or improve when the dose or timing changes. If a side effect is severe, or it is not settling, that is a conversation to have with a prescriber rather than a reason to stop on your own.

Sleep, weight, and sexual effects

For sleep and appetite, the two are broadly similar. Both can make it harder to fall asleep, especially if taken later in the day, which is why timing matters and why both are generally taken in the morning. A steadier formulation that wears off by evening can help with sleep for some people. Both tend to reduce appetite, which can lead to some weight loss, and the appetite effect is often strongest early on. Practical steps help, such as eating a good breakfast before the medication takes full effect and having a meal or snack when appetite returns later in the day. In children, stimulants can slightly slow growth, so a prescriber tracks height and weight over time. Sexual side effects are less of a defining feature for stimulants than for antidepressants, but changes in sex drive can occur with either. Any of these effects is worth raising with a prescriber, since timing, dose, or formulation can often be adjusted.

Why a clinician might choose one over the other

Because the two are closely related, the choice often comes down to specifics rather than to one being clearly stronger.

A clinician might lean toward Vyvanse for a smooth, consistent, once-daily effect, especially for someone who wants to take a single dose and have steady coverage from morning into the evening. It may also be considered where a more misuse-resistant option is preferred, or where binge eating disorder is present alongside ADHD. As an example, an adult who struggles with rebound irritability in the late afternoon on a shorter-acting stimulant may do better on the smoother profile of Vyvanse.

A clinician might lean toward Adderall when flexibility matters. Extended-release Adderall is widely used for once-daily coverage and is a reasonable alternative to Vyvanse. Immediate-release Adderall offers shorter or more flexible coverage, which can help when someone needs a stimulant only at certain times of day, or as an add-on to extend coverage in the evening. As an example, a college student who needs sharp focus for a few hours of study but does not want all-day coverage may prefer an immediate-release option.

Beyond those points, individual response, cost, and insurance coverage often decide. The same dose can feel different from one person to the next, so some trial is normal. Trying one, then adjusting the dose, timing, or formulation, is a standard part of treatment.

The bottom line

Adderall and Vyvanse are closely related amphetamine stimulants. Vyvanse's prodrug design gives it a smoother, longer, more misuse-resistant profile and a once-daily effect, and it is also approved for binge eating disorder in adults. Adderall offers both long-acting and short-acting options, which gives it more flexibility for people who need coverage only at certain times. The right choice is individual, and it is made with a prescriber. Trying one and adjusting is a normal step in treatment.

Common questions

Is Vyvanse stronger than Adderall? Neither is simply stronger. Both are effective amphetamine-based stimulants. They differ mostly in how the dose is delivered. Vyvanse has a smooth, long, once-daily effect, while Adderall comes in short-acting and long-acting forms. The doses are not directly interchangeable, so a prescriber adjusts to find the right dose for each medication.

Why does Vyvanse last longer than immediate-release Adderall? Vyvanse is a prodrug. It is inactive as taken, and the body converts it gradually into the active stimulant. That gradual conversion is why it comes on smoothly and lasts most of the day. Immediate-release Adderall is active as taken, so it comes on faster and wears off after a few hours.

Can I switch from one to the other? Many people do try both, and a poor response or a tolerability problem with one does not mean the other will not work. Switching should be planned with a prescriber, since the doses are not equivalent and the timing of the change matters.

Which one is less likely to be misused? Vyvanse is somewhat harder to misuse because the body has to convert it before it becomes active. Immediate-release Adderall is more readily misused. Both are still Schedule II controlled substances and carry the same boxed warning, so both are prescribed and monitored carefully.

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes.

  1. U.S. Food and Drug Administration. Adderall (amphetamine salts) prescribing information.
  2. U.S. Food and Drug Administration. Vyvanse (lisdexamfetamine) prescribing information.
  3. MedlinePlus, U.S. National Library of Medicine.
  4. National Institute of Mental Health. Mental health medications.

Some clinicians and practices don't prescribe controlled substances like these. Why some practices don't prescribe these at shrinkMD.

Your next step in The Shrink Network

You are here: PsychiatryRx, the medication education layer of The Shrink Network.

Every site in the network does one job. No matter where you start, we help you find the next step that makes sense.

Medication management at shrinkMD

shrinkMD is the network's independent telepsychiatry practice, founded by our medical editor. It's one option among many. PsychiatryRx runs no ads, sells nothing, and earns no referral fees.

Want to understand more first?

Managing a medication needs a prescriber

Any psychiatric medication has to be started and adjusted by a clinician who can follow you over time. If you don't have a prescriber, our guides section explains the options, including in-person care and telepsychiatry, and how to choose between them.